Compare with NOVONESIS A S


Market capitalization
‪29.80 B‬ USD
1.58 USD
‪658.64 M‬ USD
‪4.69 B‬ USD
‪412.50 M‬
Beta (1Y)
0.08
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Company info


CEO
Ester Baiget
Headquarters
Lyngby
IPO date
May 27, 1905
ISIN
US6701081092
CUSIP
670108109
FIGI
BBG000F9LZC9
Identifiers
ISIN US6701081092
Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMar 19, 2037
Coupon4.00% (Fixed)
Maturity dateMar 19, 2033
Coupon3.63% (Fixed)
Maturity dateMar 19, 2030
Coupon3.25% (Fixed)

See all NVZMY bonds 

Weight0.08%
Market value‪900.06 K‬
Weight0.10%
Market value‪250.99 K‬
Weight0.01%
Market value‪5.08 K‬

Explore more ETFs